Tag Archives: GTXI

Top Performing Stocks To Invest In Right Now

At $257,200.00 a share, investing in Berkshire Hathaway Inc. (NYSE: BRK.A) is simply not an option for most retail investors like us. But the nearly 50 other “Warren Buffett stocks” that Berkshire invests in come at a much lower price point.

While we at Money Morning don’t recommend all of Warren Buffett’s stock picks for retail investors, our experts do like a lot of them. One in particular is a stock Money Morning Director of Technology & Venture Capital Michael A. Robinson recently recommended.

But before we get to the stock pick, here’s a list of the 10 top-performing Warren Buffett stocks so far this year…

Company YTD Gains
Moody’s Corp. (NYSE: MCO) 34.25%
Apple Inc. (Nasdaq: AAPL) 30.24%
Verisign Inc. (Nasdaq: VRSN) 29.88%
Restaurant Brands Inc. (NYSE: QSR) 29.16%
WABCO Holdings Inc. (NYSE: WBC) 28.97%
Visa Inc. (NYSE: V) 26.20%
Liberty Sirius XM Group Class C (Nasdaq: LSXMK) 24.54%
MasterCard Inc. (NYSE: MA) 24.35%
Liberty Sirius XM Group Class A (Nasdaq: LSXMA) 22.89%
Sirius XM Holdings Inc. (Nasdaq: SIRI) 22.81%

Again, we don’t recommend all of the stocks above for retail investors. After all, Warren Buffett is one of the most wealthy and legendary investors in history. He has a completely different set of goals from us.

Top Performing Stocks To Invest In Right Now: Applied DNA Sciences Inc(APDN)

Advisors’ Opinion:

  • [By Shane Hupp]

    Ascent Capital Group (NASDAQ: ASCMA) and Applied DNA Sciences (NASDAQ:APDN) are both small-cap industrial products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, risk, profitability, earnings and institutional ownership.

  • [By Ethan Ryder]

    NV5 Global (NASDAQ: NVEE) and Applied DNA Sciences (NASDAQ:APDN) are both small-cap business services companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, institutional ownership, risk, valuation and dividends.

  • [By Max Byerly]

    These are some of the media headlines that may have effected Accern Sentiment’s rankings:

    Get Applied DNA Sciences alerts:

    Applied DNA Sciences’ (APDN) CEO James Hayward on Q2 2018 Results – Earnings Call Transcript (seekingalpha.com) Edited Transcript of APDN earnings conference call or presentation 3-May-18 8:30pm GMT (finance.yahoo.com) Applied DNA Sciences: Fiscal 2Q Earnings Snapshot (finance.yahoo.com) Applied DNA Sciences (APDN) Stock Rating Upgraded by ValuEngine (americanbankingnews.com) Applied DNA Reports Fiscal Second Quarter 2018 Financial Results (finance.yahoo.com)

    A number of research analysts have issued reports on the stock. Maxim Group set a $5.00 price target on shares of Applied DNA Sciences and gave the stock a “buy” rating in a report on Friday, April 6th. ValuEngine raised shares of Applied DNA Sciences from a “strong sell” rating to a “sell” rating in a report on Friday, February 2nd.

  • [By Logan Wallace]

    NV5 Global (NASDAQ: NVEE) and Applied DNA Sciences (NASDAQ:APDN) are both small-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends and risk.

Top Performing Stocks To Invest In Right Now: GTx Inc.(GTXI)

Advisors’ Opinion:

  • [By Chris Lange]

    GTx Inc. (NASDAQ: GTXI) will present additional data demonstrating duration of response following completion of treatment for its Phase 2 proof-of-concept clinical trial evaluating enobosarm 3 mg in postmenopausal women with stress urinary incontinence at the upcoming 2018 American Urological Association meeting on May 18.

  • [By Stephan Byrd]

    GTx, Inc. (NASDAQ:GTXI) was down 6.4% during mid-day trading on Friday after an insider sold shares in the company. The company traded as low as $17.10 and last traded at $17.30. Approximately 726,400 shares traded hands during trading, an increase of 492% from the average daily volume of 122,740 shares. The stock had previously closed at $18.49.

  • [By Ethan Ryder]

    GTx, Inc. (NASDAQ:GTXI) insider Jason T. Shackelford sold 9,279 shares of the business’s stock in a transaction dated Wednesday, June 20th. The stock was sold at an average price of $19.01, for a total transaction of $176,393.79. Following the sale, the insider now directly owns 19,453 shares in the company, valued at $369,801.53. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Top Performing Stocks To Invest In Right Now: NanoString Technologies, Inc.(NSTG)

Advisors’ Opinion:

  • [By Ethan Ryder]

    NanoString Technologies (NASDAQ: NSTG) is one of 91 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it contrast to its competitors? We will compare NanoString Technologies to related businesses based on the strength of its earnings, profitability, institutional ownership, dividends, risk, valuation and analyst recommendations.

  • [By Lisa Levin] Gainers
    Forward Pharma A/S (NASDAQ: FWP) shares gained 88.18 percent to close at $4.14 on Tuesday.
    Regional Health Properties, Inc. (NYSE: RHE) shares jumped 18.04 percent to close at $0.3010 on Tuesday.
    Precipio, Inc. (NASDAQ: PRPO) shares gained 16.61 percent to close at $0.49 after the nano-cap specialty diagnostics company said it saw an acceleration of sales in its Pathology services in April. The company now expects to see a sequential double digit quarterly sales growth.
    Arcturus Therapeutics Ltd. (NASDAQ: ARCT) rose 16.09 percent to close at $7.00 on Tuesday.
    America's Car-Mart, Inc. (NASDAQ: CRMT) gained 14.53 percent to close at $62.65 after reporting upbeat Q4 results.
    NanoString Technologies, Inc. (NASDAQ: NSTG) shares surged 12.64 percent to close at $13.19.
    Geron Corporation (NASDAQ: GERN) gained 12.12 percent to close at $4.07 on Tuesday.
    Quotient Limited (NASDAQ: QTNT) shares climbed 11.58 percent to close at $6.55 on Tuesday.
    American Equity Investment Life Holding Company (NYSE: AEL) rose 11.23 percent to close at $32.28 following a report from Reuters that the company is looking for a sale.
    iQIYI, Inc. (NASDAQ: IQ) gained 11.15 percent to close at $22.52.
    Veracyte, Inc. (NASDAQ: VCYT) rose 10.4 percent to close at $7.11.
    Stein Mart, Inc. (NASDAQ: SMRT) gained 10.26 percent to close at $3.33. Stein Mart is expected to release quarterly earnings on May 23.
    MiMedx Group, Inc. (NASDAQ: MDXG) shares rose 10.11 percent to close at $8.06.
    The Container Store Group, Inc. (NYSE: TCS) gained 8.2 percent to close at $8.18. Container Store reported weaker-than-expected earnings for its fourth quarter after the closing bell.
    Photronics, Inc. (NASDAQ: PLAB) shares gained 7.69 percent to close at $9.10 after the company reported upbeat Q2 results.
    Micron Technology, Inc. (NASDAQ: MU) rose 6.4 percent to close at $59.03 after reporting a $10 billion buyback plan.

     

Top Performing Stocks To Invest In Right Now: Utah Medical Products, Inc.(UTMD)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Utah Medical Products (NASDAQ:UTMD) was upgraded by investment analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Monday.

  • [By Max Byerly]

    Utah Medical Products, Inc. (NASDAQ:UTMD) CEO Kevin L. Cornwell sold 8,080 shares of the firm’s stock in a transaction on Friday, June 15th. The stock was sold at an average price of $107.07, for a total value of $865,125.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

  • [By Max Byerly]

    Utah Medical Products, Inc. (NASDAQ:UTMD) Director Ernst G. Hoyer sold 1,614 shares of the company’s stock in a transaction that occurred on Wednesday, May 9th. The stock was sold at an average price of $104.41, for a total value of $168,517.74. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Top Performing Stocks To Invest In Right Now: Landec Corporation(LNDC)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Landec (LNDC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Landec (NASDAQ: LNDC) and Seneca Foods Corp Class A (NASDAQ:SENEA) are both small-cap consumer staples companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, earnings, profitability and dividends.

Top 10 Performing Stocks To Buy For 2019

March 10, 2017: Markets opened higher Friday following another month of strong non-farm payroll gains. Top performing sectors today were industrials, telecoms, and utilities. The weakest performer was real-estate. WTI crude oil for April delivery settled at $48.49 a barrel, down 1.6% on the day and down more than 9% for the week. April gold dropped 0.2% on the day to settle at $1,201.40. Equities were headed for a higher close shortly before the bell as the DJIA traded up 0.20% for the day, the S&P 500 traded up 0.28%, and the Nasdaq Composite traded up 0.35%.

The DJIA stock posting the largest daily percentage gain ahead of the close Friday was General Electric Co. (NYSE: GE) which traded up 2.14% at $30.30. The stock’s 52-week range is $28.19 to $33.00. Shares got a boost on a report that CEO Jeff Immelt is being pushed to retire.

UnitedHealth Group Inc. (NYSE: UNH) traded up 1.11% at $169.87. The stock’s 52-week range is $122.22 to $3170.00, a new high posted this afternoon. Volume was about 30% below the daily average of around 3.5 million shares. The company had no specific news Friday.

Top 10 Performing Stocks To Buy For 2019: ARMOUR Residential REIT, Inc.(ARR)

Advisors’ Opinion:

  • [By Joseph Griffin]

    ARMOUR Residential REIT (NYSE:ARR) was the target of some unusual options trading activity on Thursday. Stock traders acquired 657 call options on the stock. This represents an increase of approximately 1,163% compared to the typical volume of 52 call options.

Top 10 Performing Stocks To Buy For 2019: Jazz Pharmaceuticals Inc.(JAZZ)

Advisors’ Opinion:

  • [By Lee Jackson]

    This top company is a favorite across Wall Street.Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) is a biopharmaceutical company that identifies, develops and commercializes pharmaceutical products for various medical needs in the United States, Europe and elsewhere. The company has a portfolio of products and product candidates with a focus in the areas of sleep and hematology/oncology.

  • [By Logan Wallace]

    Swiss National Bank trimmed its holdings in shares of Jazz Pharmaceuticals (NASDAQ:JAZZ) by 13.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 192,000 shares of the specialty pharmaceutical company’s stock after selling 29,100 shares during the quarter. Swiss National Bank owned 0.32% of Jazz Pharmaceuticals worth $28,990,000 at the end of the most recent reporting period.

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Marriott International, Inc. (NASDAQ: MAR) is projected to post quarterly earnings at $1.22 per share on revenue of $5.72 billion.
    Electronic Arts Inc. (NASDAQ: EA) is estimated to post quarterly earnings at $1.04 per share on revenue of $5.68 billion.
    The Walt Disney Company (NYSE: DIS) is projected to post quarterly earnings at $1.68 per share on revenue of $14.05 billion.
    Papa John's International, Inc. (NASDAQ: PZZA) is expected to post quarterly earnings at $0.62 per share on revenue of $441.73 million.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is projected to post quarterly earnings at $2.77 per share on revenue of $434.87 million.
    Sun Life Financial Inc. (NYSE: SLF) is estimated to post quarterly earnings at $0.89 per share on revenue of $6.38 billion.
    LATAM Airlines Group S.A. (NYSE: LTM) is expected to post quarterly earnings at $0.16 per share on revenue of $2.70 billion.
    Liberty Global plc (NASDAQ: LBTYA) is projected to post quarterly earnings at $0.02 per share on revenue of $4.05 billion.
    TripAdvisor, Inc. (NASDAQ: TRIP) is expected to post quarterly earnings at $0.16 per share on revenue of $362.11 million.
    The Wendy's Company (NASDAQ: WEN) is projected to post quarterly earnings at $0.1 per share on revenue of $379.98 million.
    A-Mark Precious Metals, Inc. (NASDAQ: AMRK) is expected to post quarterly earnings at $0.06 per share on revenue of $1.69 billion.
    Monster Beverage Corporation (NASDAQ: MNST) is estimated to post quarterly earnings at $0.4 per share on revenue of $849.38 million.
    Convergys Corporation (NYSE: CVG) is expected to post quarterly earnings at $0.4 per share on revenue of $670.10 million.
    ScanSource, Inc. (NASDAQ: SCSC) is projected to post quarterly earnings at $0.7 per share on revenue of $875.91 million.
    KAR Auction Services, Inc. (NYSE: KAR) is expected to post quarterly earnings at $0.76 per share on revenue of $923.13

Top 10 Performing Stocks To Buy For 2019: Valeant Pharmaceuticals International Inc(VRX)

Advisors’ Opinion:

  • [By Logan Wallace]

    Valeant Pharmaceuticals International Inc (NYSE:VRX) (TSE:VRX) – Analysts at Jefferies Group reduced their Q3 2018 earnings per share (EPS) estimates for shares of Valeant Pharmaceuticals International in a research report issued to clients and investors on Tuesday, May 8th. Jefferies Group analyst D. Steinberg now anticipates that the specialty pharmaceutical company will earn $0.70 per share for the quarter, down from their prior forecast of $0.73. Jefferies Group currently has a “Buy” rating and a $23.00 target price on the stock. Jefferies Group also issued estimates for Valeant Pharmaceuticals International’s Q4 2018 earnings at $0.71 EPS and FY2022 earnings at $5.50 EPS.

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares rose 14.1 percent to $3.65 in the pre-market trading session after reporting 2017 year-end results.
    LightPath Technologies, Inc. (NASDAQ: LPTH) rose 13.3 percent to $2.43 in pre-market trading after reporting a third-quarter earnings beat.
    MYnd Analytics, Inc. (NASDAQ: MYND) rose 10.5 percent to $3.49 in pre-market trading. MYnd Analytics reported a Q2 net loss of $2.7 million on revenue of $459,900.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares rose 8.4 percent to $5.68 in pre-market trading after reporting upbeat Q1 results.
    Famous Dave's of America, Inc. (NASDAQ: DAVE) shares rose 7.7 percent to $8.40 in pre-market trading after the company reported upbeat earnings for its first quarter on Monday.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 7.5 percent to $6.45 in pre-market trading after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    Mimecast Ltd (NASDAQ: MIME) rose 6.5 percent to $43.50 in pre-market trading following a first-quarter sales beat.
    Boxlight Corporation (NASDAQ: BOXL) rose 6 percent to $12.50 in pre-market trading after surging 77.44 percent on Monday.
    Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares rose 6 percent to $26.05 in pre-market trading after climbing 3.58 percent on Monday.
    PPDAI Group Inc. (NASDAQ: PPDF) rose 4.7 percent to $7.20 in pre-market trading following Q1 results.
    Xunlei Limited (NASDAQ: XNET) rose 4.1 percent to $13.88 in pre-market trading after gaining 2.54 percent on Monday.
    Valeant Pharmaceuticals International, Inc. (NYSE: VRX) shares rose 4.5 percent to $21.73 in pre-market trading. Mizuho upgraded Valeant from Neutral to Buy.
    Bovie Medical Corporation (NYSE: BVX) rose 4.1 percent to $3.80 in pre-market trading after reporting a first-quarter sales beat.
    Myomo, Inc. (NYSE: MYO) rose 3.4 percent to $4.00 in pre-market trading after jumping 23.25 percent o
  • [By Lee Jackson]

    This company has been fighting its way back now for over a year and may be a very solid contrarian play. Valeant Pharmaceuticals International Inc. (NYSE: VRX) operates as a multinational, specialty pharmaceutical and medical device company that develops, manufactures and markets a range of pharmaceuticals, over-the-counter (OTC) products and medical devices. The company operates through three segments: Bausch + Lomb/International, Branded Rx and U.S. Diversified Products.

  • [By ]

    Sometimes it’s better to raise funds when you can vs. when you have to. Look no farther than Valeant Pharmaceuticals (VRX) , which is in a massive hole of debt and trades below $20 per share. It sure would have been nice to raise capital in a secondary offering with the stock over $200 per share for six months throughout 2015. 

  • [By Chris Lange]

    Valeant Pharmaceuticals International Inc. (NYSE: VRX) released its most recent quarterly report before the markets opened on Tuesday. At the same time, the firm announced that it would also be changing its name sometime in the very near future.

  • [By Dan Caplinger]

    The stock market finally hit some resistance on Tuesday, giving up ground and breaking a long streak of consecutive advances for most major benchmarks. Market participants got spooked by a rise in interest rates, with 10-year Treasury yields once again climbing above the 3% mark and leading some to predict even steeper advances in the future. With budget deficits ballooning, higher interest expenses on the national debt could have a dramatic impact on the U.S. economy, especially if it lures investors away from high-flying stocks. Yet even amid the bond-driven downturn, some individual companies saw good news lift their shares. Valeant Pharmaceuticals International (NYSE:VRX), Hollysys Automation Technologies (NASDAQ:HOLI), and Ascena Retail Group (NASDAQ:ASNA) were among the best performers on the day. Here’s why they did so well.

Top 10 Performing Stocks To Buy For 2019: Boot Barn Holdings, Inc.(BOOT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Macy's, Inc. (NYSE: M) to report quarterly earnings at $0.35 per share on revenue of $5.39 billion before the opening bell. Macy's shares fell 0.47 percent to $29.79 in after-hours trading.
    Analysts are expecting Cisco Systems, Inc. (NASDAQ: CSCO) to have earned $0.65 per share on revenue of $12.43 billion in the latest quarter. Cisco will release earnings after the markets close. Cisco shares declined 0.07 percent to $45.45 in after-hours trading.
    Boot Barn Holdings Inc (NYSE: BOOT) reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance. Boot Barn shares climbed 9.97 percent to $24.15 in the after-hours trading session.
    After the markets close, Flowers Foods, Inc. (NYSE: FLO) is projected to post quarterly earnings at $0.31 per share on revenue of $1.20 billion. Flowers Foods shares dropped 0.37 percent to $21.70 in after-hours trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares climbed 17.4 percent to $3.11. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Flanigan's Enterprises, Inc. (NYSE: BDL) shares jumped 17 percent to $27.97 following Q2 results. Flanigan's Enterprises posted Q2 earnings of $0.75 per share on sales of $29.456 million.
    Borqs Technologies, Inc. (NASDAQ: BRQS) rose 15.8 percent to $8.05 after reporting Q1 results.
    Abaxis, Inc. (NASDAQ: ABAX) jumped 15.3 percent to $82.75. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    21Vianet Group, Inc. (NASDAQ: VNET) gained 15.1 percent to $6.33.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) rose 13.8 percent to $6.27.
    Enphase Energy, Inc. (NASDAQ: ENPH) gained 12.8 percent to $5.98. H.C. Wainwright initiated coverage on Enphase Energy with a Buy rating.
    PetIQ Inc (NASDAQ: PETQ) shares surged 12.1 percent to $21.68 after reporting a first-quarter sales beat.
    NF Energy Saving Corporation (NASDAQ: NFEC) climbed 11.6 percent to $2.399.
    Allied Healthcare Products, Inc. (NASDAQ: AHPI) surged 11.4 percent to $3.0643.
    Boot Barn Holdings, Inc. (NYSE: BOOT) gained 11.1 percent to $24.40 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) rose 10.9 percent to $3.16.
    Sea Limited (NYSE: SE) gained 10.1 percent to $11.71 after reporting Q1 results.
    GEE Group, Inc. (NYSE: JOB) climbed 7.9 percent to $2.61 following Q2 results.
    The ONE Group Hospitality, Inc. (NASDAQ: STKS) gained 7.6 percent to $2.41 after reporting Q1 results.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX) rose 7.3 percent to $0.8798 after the company was granted a patent approval. The clinical-st
  • [By Lisa Levin]

    Shares of Boot Barn Holdings, Inc. (NYSE: BOOT) got a boost, shooting up 13 percent to $24.815 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.

  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares climbed 31.68 percent to close at $7.19 on Wednesday. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares gained 24.15 percent to close at $3.29. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    21Vianet Group, Inc. (NASDAQ: VNET) shares surged 24 percent to close at $6.82.
    Check-Cap Ltd. (NASDAQ: CHEK) gained 20.25 percent to close at $4.87.
    HUYA Inc. (NYSE: HUYA) shares surged 18.42 percent to close at $22.50
    Abaxis, Inc. (NASDAQ: ABAX) rose 16.15 percent to close at $83.34. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    Pain Therapeutics, Inc. (NASDAQ: PTIE) shares jumped 16.07 percent to close at $10.62.
    Bilibili Inc. (NASDAQ: BILI) rose 16.04 percent to close at $14.11.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) gained 14.88 percent to close at $6.33.
    Phoenix New Media Limited (NYSE: FENG) rose 13.96 percent to close at $5.55.
    Daqo New Energy Corp. (NYSE: DQ) jumped 13.88 percent to close at $67.27 on Wednesday.
    Sea Limited (NYSE: SE) jumped 12.59 percent to close at $11.98 after reporting Q1 results.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) rose 12.01 percent to close at $5.13.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) gained 11.93 percent to close at $3.19.
    Boot Barn Holdings, Inc. (NYSE: BOOT) climbed 11.66 percent to close at $24.52 on Wednesday after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Macy's, Inc. (NYSE: M) rose 10.83 percent to close at $33.17 after the company reported stronger-than-expected results for its first quarter and lifted guidance.
    ChemoCentryx, Inc. (NASDAQ: CCXI) gained 9.36 percent to close at $12.50. Canaccord Genuity initiated coverage on ChemoCentryx with a Buy rating.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX)

Top 10 Performing Stocks To Buy For 2019: Culp, Inc.(CFI)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Cofound.it (CURRENCY:CFI) traded down 2.1% against the U.S. dollar during the 24-hour period ending at 21:00 PM Eastern on May 12th. In the last week, Cofound.it has traded down 21% against the U.S. dollar. One Cofound.it token can currently be purchased for about $0.0769 or 0.00000911 BTC on major exchanges including Liqui, IDEX, HitBTC and Upbit. Cofound.it has a total market capitalization of $25.01 million and approximately $314,252.00 worth of Cofound.it was traded on exchanges in the last day.

Top 10 Performing Stocks To Buy For 2019: Sanofi(SNY)

Advisors’ Opinion:

  • [By Todd Campbell]

    When a brand new class of cholesterol-lowering drugs called PCSK9 inhibitors won Food and Drug Administration (FDA) approval in 2015, it was heralded as the biggest advance in battling heart disease since the invention of statins. The launch of PCSK9 inhibitors was accompanied by billion-dollar-plus predictions for sales. However, revenue has fallen far shy of blockbuster status, leaving drugmakers Amgen Inc. (NASDAQ:AMGN), Regeneron Pharmaceuticals (NASDAQ:REGN), and Sanofi SA (NYSE:SNY) in the lurch.

  • [By Cory Renauer]

    Sanofi (NYSE:SNY) andRegeneron (NASDAQ:REGN) launched a cholesterol-lowering treatment in 2015 that could be a big problem for bempedoic acid, even if its safety profile remains intact. Praluent is a remarkable drug that can turn stubborn liver cells into cholesterol sponges, but at an initial list price of around $14,000 per year, its launch was a huge disappointment.

  • [By Keith Speights]

    Alnylam’s partner, Sanofi (NYSE:SNY), is taking the lead on a phase 3 study of another experimental RNAi therapeutic,fitusiran, in treating hemophilia A and B. Sanofi now has global rights to the drug as a result of a restructuring of the two companies’ rare disease collaboration agreement signed in 2014. Alnylam stands to receive royalties between 15% and 30% of any future sales for fitusiran.

Top 10 Performing Stocks To Buy For 2019: S&W Seed Company(SANW)

Advisors’ Opinion:

  • [By Ethan Ryder]

    S&w Seed (NASDAQ:SANW) – Equities researchers at B. Riley decreased their Q3 2019 earnings per share (EPS) estimates for S&w Seed in a research note issued to investors on Thursday, May 10th. B. Riley analyst S. Sherbetchyan now anticipates that the company will post earnings of $0.00 per share for the quarter, down from their previous forecast of $0.01. B. Riley has a “Buy” rating and a $5.50 price objective on the stock.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on S&w Seed (SANW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Performing Stocks To Buy For 2019: GTx Inc.(GTXI)

Advisors’ Opinion:

  • [By Chris Lange]

    GTx Inc. (NASDAQ: GTXI) will present additional data demonstrating duration of response following completion of treatment for its Phase 2 proof-of-concept clinical trial evaluating enobosarm 3 mg in postmenopausal women with stress urinary incontinence at the upcoming 2018 American Urological Association meeting on May 18.

Top 10 Performing Stocks To Buy For 2019: Simulations Plus, Inc.(SLP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Simulations Plus (SLP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Simulations Plus (NASDAQ:SLP) shares hit a new 52-week high and low during mid-day trading on Monday . The company traded as low as $18.55 and last traded at $18.35, with a volume of 49668 shares changing hands. The stock had previously closed at $18.20.

  • [By Ethan Ryder]

    Simulations Plus (NASDAQ:SLP) was upgraded by equities research analysts at ValuEngine from a “buy” rating to a “strong-buy” rating in a research report issued on Monday.

Top 10 Performing Stocks To Buy For 2019: ENERGY TRANSFER PARTNERS(ETP)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    While ONEOK is one of the largest energy infrastructure companies in the country, one thing others have that it lacks is an export terminal. An analyst on the call pointed this out and asked how aggressively the company was pursuing exports given that rivals Enterprise Products Partners (NYSE:EPD) and Energy Transfer Partners (NYSE:ETP) recently signed joint ventures (JVs) to build new export terminals. In Enterprise’s case, it signed a JV to construct an ethylene export facility to move the key petrochemical to market centers. Meanwhile, Energy Transfer secured a JV to build an ethane export facility. Both projects should start up in 2020 and supply thesecompanies with steady cash flow for years via long-term, fee-based contracts.

  • [By Matthew DiLallo]

    The market has pummeled master limited partnerships (MLPs) over the past few years due to the impact the oil market downturn had on their operations and business model. Among the hardest-hit have been oil pipeline MLP Plains All American Pipeline (NYSE:PAA) and gas pipeline giant Energy Transfer Partners (NYSE:ETP), both of which have lost more than half their value over the last three years. That persistent slump comes even though their turnaround strategies are beginning to gain steam. While these companies still have some work to do before they’re back on solid ground, both could deliver significant returns as they complete their plans and the oil market continues rebounding over the next few years. That upside potential makes them compelling options for investors with a higher tolerance for risk.

  • [By ]

    Energy Transfer Partners LP (NYSE: ETP)
    Formerly Sunoco Logistics Partners, ETP focuses on transport and storage of crude oil, refined products, and natural gas liquids (NGLs). Headquartered in Texas (where else?), ETP manages a portfolio that includes more than 71,000 miles of pipeline as well as marketing services.

  • [By Steve Symington, John Bromels, and Keith Noonan]

    So we asked three Motley Fool contributors exactly that. Read on to learn why they like Retail Opportunity Investments (NASDAQ:ROIC), Energy Transfer Partners (NYSE:ETP), and GameStop (NYSE:GME).

  • [By Matthew DiLallo]

    After facing several challenges over the past few years, Energy Transfer Partners(NYSE:ETP) has turned things around, which was evident in its first-quarter results. Earnings and cash flow jumped thanks to recent project completions, while a string of asset sales and other strategic financing initiatives have helped bolster its balance sheet and ability to fund additional growth projects. While the company still has some work to do before all its issues are in the rearview mirror, it’s certainly heading in the right direction.

  • [By Danny Vena, John Bromels, and Demitrios Kalogeropoulos]

    As appetizing as that dividend is, there are other companies that offer an even tastier yield. With that in mind, we asked three Motley Fool investors to choose top companies that would provide investors an even more generous payout. They offered compelling arguments for National Retail Properties (NYSE:NNN), Energy Transfer Partners, LLP (NYSE:ETP), and DSW Inc. (NYSE:DSW).

Best Blue Chip Stocks To Invest In Right Now

U.S. stocks opened firmly higher on Thursday, extending a late-session rally from the prior session, as investors dialed back on fears that a trade spat between the U.S. and China will materialize.

The major equity indexes staged a big turnaround Wednesday after opening sharply lower, as traders struggled to interpret the possible impact of the trade standoff on U.S. corporate earnings and growth.

What are main benchmarks doing?

Dow Jones Industrial Average
DJIA, +0.69%
rise rose about 150 points, or 0.6%, to 24,410. Blue chips are attempting to mark their first three-session win streak since the three-day period ended Feb. 26, according to FactSet data. The S&P 500 index
SPX, +0.46%
was up 12 points, or 0.4%, to 2,656, led by a 1.2% gain in energy and a 0.8% climb in technology stocks.

Best Blue Chip Stocks To Invest In Right Now: GTx Inc.(GTXI)

Advisors’ Opinion:

  • [By Chris Lange]

    GTx Inc. (NASDAQ: GTXI) will present additional data demonstrating duration of response following completion of treatment for its Phase 2 proof-of-concept clinical trial evaluating enobosarm 3 mg in postmenopausal women with stress urinary incontinence at the upcoming 2018 American Urological Association meeting on May 18.

Best Blue Chip Stocks To Invest In Right Now: TrueBlue Inc.(TBI)

Advisors’ Opinion:

  • [By Logan Wallace]

    Trueblue (NYSE: TBI) is one of 23 public companies in the “Help supply services” industry, but how does it contrast to its rivals? We will compare Trueblue to similar businesses based on the strength of its analyst recommendations, institutional ownership, valuation, profitability, dividends, earnings and risk.

Best Blue Chip Stocks To Invest In Right Now: Amtech Systems Inc.(ASYS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    ValuEngine cut shares of Amtech Systems (NASDAQ:ASYS) from a hold rating to a sell rating in a research note published on Wednesday morning.

    Separately, Zacks Investment Research raised Amtech Systems from a sell rating to a hold rating in a research report on Monday, April 16th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the company’s stock. The company has a consensus rating of Hold and an average target price of $14.88.

  • [By Lisa Levin] Gainers
    The Trade Desk, Inc. (NASDAQ: TTD) jumped 36.2 percent to $71.82 after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    WideOpenWest, Inc. (NYSE: WOW) jumped 30.4 percent to $8.80 after the company reported Q1 results.
    MoSys, Inc. (NASDAQ: MOSY) shares surged 28.6 percent to $1.9541 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    Boxlight Corporation (NASDAQ: BOXL) gained 24 percent to $6.39.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) shares gained 19.1 percent to $24.60. Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals Inc (NASDAQ: IONS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee, which met to discuss the safety and efficacy of subcutaneously injected volanesoren solution for patients with familial chylomicronemia syndrome, voted 12-8 to support its approval.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 17 percent to $10.31 after reporting Q3 results.
    ArcBest Corporation (NASDAQ: ARCB) gained 16.8 percent to $43.1457 after reporting upbeat quarterly earnings.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 16.2 percent to $8.60. Amtech posted Q2 earnings of $0.19 per share on sales of $32.783 million.
    Identiv, Inc (NASDAQ: INVE) surged 14.4 percent to $3.8450 following Q1 results.
    Omeros Corporation (NASDAQ: OMER) shares rose 14.3 percent to $18.43 following Q1 results.
    VivoPower International PLC (NASDAQ: VVPR) gained 11.5 percent to $2.71.
    Intersections Inc. (NASDAQ: INTX) gained 11.4 percent to $2.55 after reporting Q1 results.
    Noodles & Company (NASDAQ: NDLS) shares rose 10.9 percent to $8.65 following Q1 results.
    Voyager Therapeutics, Inc. (NASDAQ: VYGR) climbed 10.6 percent to $18.54 following Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) rose 10.4 percent to $5.739.
    Immersion Corporation (NASDAQ: IMMR) gained 9.6 percent to $12.69

Best Blue Chip Stocks To Invest In Right Now: National Commerce Corporation(NCOM)

Advisors’ Opinion:

  • [By Logan Wallace]

    National Commerce (NASDAQ:NCOM) was downgraded by BidaskClub from a “strong-buy” rating to a “buy” rating in a research report issued on Friday.

Best Blue Chip Stocks To Invest In Right Now: Stag Industrial, Inc.(STAG)

Advisors’ Opinion:

  • [By Lee Jackson]

    STAG Industrial Inc. (NYSE: STAG) offers investors a 5.8% yield. Share recently traded hands at $24.35 apiece, in a 52-week range of $22.42 to $28.85. The consensus target price is $27.73.

Best Blue Chip Stocks To Invest In Right Now: CEVA, Inc.(CEVA)

Advisors’ Opinion:

  • [By Logan Wallace]

    CEVA (NASDAQ:CEVA) had its price objective decreased by Roth Capital to $44.00 in a research note released on Wednesday morning. Roth Capital currently has a buy rating on the semiconductor company’s stock.

  • [By Stephan Byrd]

    COPYRIGHT VIOLATION WARNING: “CEVA (CEVA) Rating Increased to Hold at BidaskClub” was posted by Ticker Report and is owned by of Ticker Report. If you are accessing this piece of content on another publication, it was copied illegally and republished in violation of US and international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.tickerreport.com/banking-finance/3370458/ceva-ceva-rating-increased-to-hold-at-bidaskclub.html.

  • [By Lisa Levin]

    CEVA, Inc. (NASDAQ: CEVA) was down, falling around 12 percent to $30.25 after the company posted weaker-than-expected Q1 profit.

    Commodities

Top 5 Performing Stocks To Watch Right Now

It’s time to see if SeaWorld Entertainment (NYSE:SEAS) can earn a treat by performing a fancy trick above water. The struggling theme park operator has a media event slated for Thursday morning at its flagship SeaWorld Orlando park. Speculation centers around the unveiling of a new sea-rescue-themed attraction, but some brand bashers hope that SeaWorld will be taking additional steps to wean itself from live marine-life entertainment.

Let’s not get too ahead of ourselves on the latter. The timing of the media fete may coincide with Takara — SeaWorld Antonio’s pregnant orca — being ready to give birth later this month, but there’s a reason why this announcement is being made in Florida instead of Texas. SeaWorld is billing Takara’s birthing process as the last killer whale born at any SeaWorld park, a slick move to distance itself from the notoriety caused by the documentary Blackfish, but Thursday’s move will probably be more about a new ride coming to its most visited park next year.

Top 5 Performing Stocks To Watch Right Now: GTx Inc.(GTXI)

Advisors’ Opinion:

  • [By Roberto Pedone]

    One biopharmaceutical player that’s rapidly moving within range of triggering a major breakout trade is GTx (GTXI), which is dedicated to the discovery, development and commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis and bone loss, muscle loss and other serious medical condition. This stock has been hammered by the bears so far in 2013, with shares off sharply by 53%.

    If you look at the chart for GTx, you’ll notice that this stock recently gapped down sharply from over $4 to below $1.50 a share with heavy downside volume. Following that gap down, shares of GTXI have rebounded sharply and started to uptrend, with the stock moving higher from its low of $1.31 to its recent high of $1.96 a share. During that move, shares of GTXI have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of GTXI within range of triggering a major breakout trade.

    Traders should now look for long-biased trades in GTXI if it manages to break out above some near-term overhead resistance at $1.96 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 1.35 million shares. If that breakout triggers soon, then GTXI will set up to re-fill some of its previous gap down zone from August that started just above $4 a share. Some possible upside targets if GTXI gets into that gap with volume are $2.50 to $3 a share, or possibly even $3.50 a share.

    Traders can look to buy GTXI off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support at $1.50 a share. One can also buy GTXI off strength once it takes out $1.96 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top 5 Performing Stocks To Watch Right Now: Franklin Covey Company(FC)

Advisors’ Opinion:

  • [By Monica Gerson]

     

    Darden Restaurants, Inc. (NYSE: DRI) is estimated to report its quarterly earnings at $1.08 per share on revenue of $1.81 billion. ConAgra Foods Inc (NYSE: CAG) is expected to report its quarterly earnings at $0.52 per share on revenue of $2.89 billion. Paychex, Inc. (NASDAQ: PAYX) is projected to report its quarterly earnings at $0.49 per share on revenue of $751.52 million. Micron Technology, Inc. (NASDAQ: MU) is expected to post a quarterly loss at $0.09 per share on revenue of $2.95 billion. McCormick & Company, Incorporated (NYSE: MKC) is estimated to report its quarterly earnings at $0.74 per share on revenue of $1.06 billion. Constellation Brands, Inc. (NYSE: STZ) is expected to report its quarterly earnings at $1.51 per share. Schnitzer Steel Industries, Inc. (NASDAQ: SCHN) is estimated to report its quarterly earnings at $0.18 per share on revenue of $356.41 million. Franklin Covey Co. (NYSE: FC) is expected to post its quarterly earnings at $0.08 per share on revenue of $49.89 million. Lindsay Corporation (NYSE: LNN) is projected to report its quarterly earnings at $0.99 per share on revenue of $148.43 million.

    Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets

Top 5 Performing Stocks To Watch Right Now: BioAmber Inc.(BIOA)

Advisors’ Opinion:

  • [By Markus Aarnio]

    BioAmber (BIOA) is a sustainable chemicals company. Its proprietary technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstock into chemicals for use in a wide variety of everyday products including plastics, resins, food additives and personal care products.

  • [By Maxx Chatsko]

    While companies with lower-priced shares are often riskier than those with higher prices, some companies trading under $5 per share have intriguing potential. Investors searching for overlooked growth opportunities should consider industrial biotech BioAmber (NYSE:BIOA), pharmaceutical services company Codexis (NASDAQ:CDXS), and one-trick-pony biopharma Keryx Biopharmaceuticals (NASDAQ:KERX).

  • [By Paul Ausick]

    BioAmber Inc. (NYSE: BIOA) dropped nearly 29% Friday to post a new 52-week low of $2.24 after closing Thursday at $3.14. Volume of more than 1.5 million shares was about 6 times the daily average of around 240,000. The company’s annual report, filed on Thursday with its quarterly results, included a “going concern” statement from the company’s independent auditing firm.

  • [By Lisa Levin]

    Bioamber Inc (NYSE: BIOA) shares dropped 19 percent to $2.55. BioAmber reported FY16 adjusted loss of $1.07 per share on revenue of $8.3 million.

Top 5 Performing Stocks To Watch Right Now: Franklin Resources, Inc.(BEN)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Franklin Resources (BEN) : “I’d rather see you in Morgan Stanley (MS) or E*TRADE Financial (ETFC) .”

    Kinder Morgan (KMI) : “They are OK now, but there are better ones.”

  • [By Craig Jones]

    Jim Strugger recommended on Bloomberg Markets a long position in Franklin Resources, Inc. (NYSE: BEN).

    He said the company is in the assets management sector and he added that the market is probably getting into the period of higher dispersion, which is usually favorable for active managers. Speaking on the positive catalysts for the stock, Strugger said Franklin Resources is going to benefit from the cash repatriation.

Top 5 Performing Stocks To Watch Right Now: Tupperware Brands Corporation(TUP)

Advisors’ Opinion:

  • [By George Budwell, Rich Smith, and Neha Chamaria]

    Keeping with this theme, our Foolish contributors think that Pfizer (NYSE:PFE),Sherwin-Williams (NYSE:SHW), andTupperware Brands (NYSE:TUP)are three large-cap dividend stocks that prove beyond a doubt that boring is beautiful when it comes to creating wealth.

  • [By Seth McNew]

    Shares ofTupperware Brands(NYSE:TUP), the classic food-storage brand that has evolved to becomemore than meets the eye, spiked as much as 12% today, after the company reported better-than-expected Q1 earnings and set positive guidance for 2017.

best stocks to buy now

California doesn’t like Trump, but sure does like tax increases. At around the same time as President Trump was being elected, California was increasing state income taxes again. The state’s high 13.3% California tax are only temporary though, just through 2030! Of course, that was back in November. It must be time for another tax hike. The latest is a move by the Golden State to tax estates, even if the feds do not.

If the federal estate tax law is repealed by President Trump and Congress, estates in California will still pay. A bill was introduced by state Sen. Scott Wiener (D-San Francisco), asking voters to keep the estate tax after all. The proposal would have to go to voters. As Mr. Wiener put it:

If Donald Trump and congressional Republicans are hell-bent on cutting taxes for our wealthiest residents, we should counter-balance those tax cuts by recapturing the lost funds and investing them here at home in our schools, our healthcare system, and our roads and public transportation systems.”

best stocks to buy now: MDC Partners Inc.(MDCA)

Advisors’ Opinion:

  • [By Lisa Levin]

    MDC Partners Inc (NASDAQ: MDCA) shares dropped 60 percent to $3.38. MDC Partners reported a Q3 loss of $0.64 per share on revenue of $349.3 million.

  • [By Lisa Levin]

    Shares of MDC Partners Inc (NASDAQ: MDCA) were down 31 percent to $12.52 after the company posted downbeat quarterly results and lowered its FY16 sales outlook.

best stocks to buy now: SORL Auto Parts Inc.(SORL)

Advisors’ Opinion:

  • [By Monica Gerson]

    Sorl Auto Parts, Inc. (NASDAQ: SORL) is expected to post its quarterly earnings at $0.20 per share on revenue of $55.35 million.

    Clean Diesel Technologies, Inc. (NASDAQ: CDTI) is projected to post a quarterly loss at $0.18 per share on revenue of $10.25 million.

  • [By Lisa Levin]

    Sorl Auto Parts, Inc. (NASDAQ: SORL) was down, falling around 8 percent to $3.68. Greenridge Global downgraded SORL Auto Parts from Buy to Hold.

best stocks to buy now: GTx Inc.(GTXI)

Advisors’ Opinion:

  • [By Roberto Pedone]

    One biopharmaceutical player that’s rapidly moving within range of triggering a major breakout trade is GTx (GTXI), which is dedicated to the discovery, development and commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis and bone loss, muscle loss and other serious medical condition. This stock has been hammered by the bears so far in 2013, with shares off sharply by 53%.

    If you look at the chart for GTx, you’ll notice that this stock recently gapped down sharply from over $4 to below $1.50 a share with heavy downside volume. Following that gap down, shares of GTXI have rebounded sharply and started to uptrend, with the stock moving higher from its low of $1.31 to its recent high of $1.96 a share. During that move, shares of GTXI have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of GTXI within range of triggering a major breakout trade.

    Traders should now look for long-biased trades in GTXI if it manages to break out above some near-term overhead resistance at $1.96 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 1.35 million shares. If that breakout triggers soon, then GTXI will set up to re-fill some of its previous gap down zone from August that started just above $4 a share. Some possible upside targets if GTXI gets into that gap with volume are $2.50 to $3 a share, or possibly even $3.50 a share.

    Traders can look to buy GTXI off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support at $1.50 a share. One can also buy GTXI off strength once it takes out $1.96 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.

best stocks to buy now: Aurora Cannabis Inc. (ACBFF)

Advisors’ Opinion:

  • [By Keith Speights]

    As increasingly more marijuana growers entered the market and more states allowed residents to legally grow marijuana, cannabis prices dropped throughout 2016. Wholesale marijuana prices late in the year were roughly half the levels of 12 months earlier. Will this trend continue — and possibly hurt leading marijuana stocks including Aphria (NASDAQOTH:APHQF),Aurora Cannabis (NASDAQOTH:ACBFF), Medical Marijuana,Inc.(NASDAQOTH:MJNA), and even GW Pharmaceuticals (NASDAQ:GWPH) in the process?

  • [By SEEKINGALPHA.COM]

    This article is for those who are hopeful of the long-term view and want to get in ahead of time. This article will compare the three front-runners of the Canadian cannabis industry, Canopy Growth Corp. (OTCPK:TWMJF), Aphria (NYSE:APH), and Aurora (OTCQX:ACBFF). Although these companies will soon have to prove themselves in a new environment, there is plenty to study right now. We will be comparing revenue growth, production capacity, valuations, and then making financial projections. The result will be a recommendation of Aurora followed by Canopy. Again this article is meant to compare competitors. The industry has the potential to be a 22.6B industry but the thesis for investing in Canadian cannabis is a separate topic and I encourage you to consider the risks.

  • [By SEEKINGALPHA.COM]

    President Trump has threatened to increase enforcement of federal cannabis laws. One might think that this will have a negative impact on marijuana and marijuana related stocks like Aurora Cannabis (OTCQB:ACBFF), General Cannabis (OTCQB:CANN), Americann (OTCQX:ACAN), and MassRoots (OTCQB:MSRT), and if implemented it probably would be devastating, both to publicly traded marijuana companies, and to local companies in regions that have legalized pot.